Population-Based Serologic Survey of Vibrio cholerae Antibody Titers before Cholera Outbreak, Haiti, 2022
Christy H. Clutter
1 , Molly B. Klarman
1, Youseline Cajusma, Emilee T. Cato, Md. Abu Sayeed, Lindsey Brinkley, Owen Jensen, Chantale Baril, V. Madsen Beau De Rochars, Andrew S. Azman, Maureen T. Long, Derek Cummings, Daniel T. Leung
2, and Eric J. Nelson
2
Author affiliations: University of Utah, Salt Lake City, Utah, USA (C.H. Clutter, O. Jensen, D.T. Leung); University of Florida, Gainesville, Florida, USA (M.B. Klarman, Y. Cajusma, E.T. Cato, M.A. Sayeed, L. Brinkley, V.M. Beau De Rochars, M.T. Long, D. Cummings, E.J. Nelson); Université d'État d'Haïti, Port au Prince, Haiti (C. Baril); Johns Hopkins University, Baltimore, Maryland, USA (A.S. Azman)
Main Article
Figure 2
Figure 2. Antibody titers by age, vaccination status, and previous history of infection among participants in a serologic study conducted before a cholera outbreak in Haiti, 2022. We compared antibody titers for lipopolysaccharide (LPS) and cholera toxin subunit B (CtxB) between children <5 years of age (n = 112) and adults and children >5 years of age for LPS IgG (A), LPS IgA (B), CtxB IgG (C), and CtxB IgA (D). We made statistical comparisons between the <5- and ≥5-year age groups using an unpaired 2-tailed Student t test. Individual year-by-year comparisons were compared using 1-way analysis of variance. Horizontal lines indicate medians; error bars indicate interquartile ranges. Significant p values are indicated.
Main Article
Page created: July 10, 2023
Page updated: August 20, 2023
Page reviewed: August 20, 2023
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.